Perma-Fix Environmental Services, Inc. 714157203 US7141572039 07/24/2025 Approve, by non-binding vote, the 2024 compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Creative Media & Community Trust Corporation 12564W219 US12564W1027 08/01/2025 To consider and approve, by a non-binding advisory vote, the executive compensation for the fiscal year ended December 31, 2024, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Lifecore Biomedical, Inc. 514766104 US5147661046 10/29/2025 To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Rezolute, Inc. 76200L309 US76200L3096 11/19/2025 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Udemy, Inc. 902685106 US9026851066 04/09/2026 To approve, on a non-binding advisory basis, certain compensation that may be paid or become payable to Udemy's named executive officers that is based on or otherwise relates to the merger contemplated by the Merger Agreement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Global Payments Inc. 37940X102 US37940X1028 04/30/2026 Approval, on an advisory basis, of the compensation of the company's named executive officers for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Baxter International Inc. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Parke Bancorp, Inc. 700885106 US7008851062 04/21/2026 To approve a non-binding advisory proposal regarding our executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Parke Bancorp, Inc. 700885106 US7008851062 04/21/2026 To approve a non-binding advisory proposal regarding the frequency with which shareholders should vote on the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Ziff Davis, Inc. 48123V102 US48123V1026 05/06/2026 To provide an advisory vote on the compensation of Ziff Davis' named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 X4 Pharmaceuticals, Inc. 98420X202 US98420X2027 05/11/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Commerce.com, Inc. 08975P108 US08975P1084 05/14/2026 Non-binding advisory vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Corbus Pharmaceuticals Holdings, Inc. 21833P301 US21833P3010 05/13/2026 Approval, on an advisory basis, of the executive compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Corbus Pharmaceuticals Holdings, Inc. 21833P301 US21833P3010 05/13/2026 To vote, on an advisory basis, on how often the Company will conduct an advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Delcath Systems, Inc. 24661P807 US24661P8077 05/13/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement (“Proxy Statement”) SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Rigel Pharmaceuticals, Inc. 766559702 US7665597024 05/14/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Geron Corporation 374163103 US3741631036 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Sprout Social, Inc. 85209W109 US85209W1099 05/20/2026 To conduct an advisory vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 SM Energy Company 78454L100 US85209W1099 05/21/2026 To approve, on a non-binding advisory basis, the compensation philosophy, policies and procedures, and the compensation of our Company’s named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Expensify, Inc. 30219Q106 US30219Q1067 05/22/2026 Approval, on an advisory basis, of the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Regenxbio Inc. 75901B107 US75901B1070 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Cars.com Inc. 14575E105 US14575E1055 06/03/2026 Advisory Approval of Executive Officer Compensation (Say on Pay) SECTION 14A SAY-ON-PAY VOTES ISSUER 3816912 0 FOR 3816912 FOR 1 2 3 Kosmos Energy Ltd. 500688106 US5006881065 05/28/2026 To provide a non-binding, advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Rapid7, Inc. 753422104 US7534221046 06/09/2026 To approve, by non-binding vote, the compensation of the Company's named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Onity Group Inc. 675746606 US6757466064 05/19/2026 Approval, on an advisory basis, of the compensation of the named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Toast, Inc. 888787108 US8887871080 06/12/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Groupon, Inc. 399473206 US3994732069 06/11/2026 To conduct a non-binding, advisory vote to approve our named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 10180970 0 FOR 10180970 FOR 1 2 3 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the 2026 proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Abeona Therapeutics Inc. 00289Y206 US00289Y2063 06/12/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Palisade Bio, Inc. 696389402 US6963894026 06/10/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Harrow, Inc. 415858109 US4158581094 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 8911422 0 FOR 8911422 FOR 1 2 3 Coursera, Inc. 22266M104 US22266M1045 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 11253669 0 FOR 11253669 FOR 1 2 3 BeOne Medicines Ltd. 07725L102 US07725L1026 06/11/2026 THAT, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0